Kintor Pharmaceutical Limited

Kintor Pharmaceutical Limitedverified

KNTPF

Price:

$0.216

Market Cap:

$789.81M

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in developing and commercializing a pipeline of small molecule and biological therapeutics for androgen-receptor-related disease areas with unmet medical needs in the People's Republic of China and internationally. The company's products pipeline include Proxalutamide, a second generation androgen receptor (AR) antagonist for the treatment of metastatic castration-resistant prostate cancer, AR positive breast cancer, and COVID-19; and Pyrilutamide, an AR antagonist for the androgenetic alopecia (AGA) and acne vulgaris treatment. Its products pipeline also comprise ALK-1 antibody for the treatment of metastatic hep...[Read more]

Industry

Biotechnology

IPO Date

2020-12-11

Stock Exchange

OTC

Ticker

KNTPF

The Current Ratio as of December 2025 (TTM) for Kintor Pharmaceutical Limited (KNTPF) is 0.44

According to Kintor Pharmaceutical Limited’s latest financial reports and current stock price. The company's current Current Ratio is 0.44. This represents a change of -65.48% compared to the average of 1.28 of the last 4 quarters.

Kintor Pharmaceutical Limited (KNTPF) Historical Current Ratio (quarterly & annually)

How has KNTPF Current Ratio performed in the past?

The mean historical Current Ratio of Kintor Pharmaceutical Limited over the last ten years is 25.75. The current 0.44 Current Ratio has changed 72.12% with respect to the historical average. Over the past ten years (40 quarters), KNTPF's Current Ratio was at its highest in in the December 2016 quarter at 130.04. The Current Ratio was at its lowest in in the June 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

25.75

Median

3.49

Minimum

1.03

Maximum

130.04

Kintor Pharmaceutical Limited (KNTPF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Kintor Pharmaceutical Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 442.22%

Maximum Annual Current Ratio = 130.04

Minimum Annual Increase = -98.28%

Minimum Annual Current Ratio = 1.03

Quarterly (TTM)
Annual
YearCurrent RatioChange
20241.03-51.00%
20232.10-55.64%
20224.74-31.74%
20216.94-17.23%
20208.39442.22%
20191.55-23.19%
20182.01-10.14%
20172.24-98.28%
2016130.0432.10%
201598.44212.49%

Kintor Pharmaceutical Limited (KNTPF) Average Current Ratio

How has KNTPF Current Ratio performed in the past?

The current Current Ratio of Kintor Pharmaceutical Limited (KNTPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.62

5-year avg

4.64

10-year avg

25.75

Kintor Pharmaceutical Limited (KNTPF) Current Ratio vs. Peers

How is KNTPF’s Current Ratio compared to its peers?

Kintor Pharmaceutical Limited’s Current Ratio is less than Paradigm Biopharmaceuticals Limited (7.46), less than Poolbeg Pharma PLC (24.94), less than Nuo Therapeutics, Inc. (1.16), less than Hofseth BioCare ASA (0.96), less than Imugene Limited (1.88), less than Satellos Bioscience Inc. (11.13), less than Scancell Holdings plc (0.77), less than Shield Therapeutics plc (0.83), less than VitaSpring Biomedical Co. Ltd. (1.97), less than Innate Pharma S.A. (2.21),

Build a custom stock screener for Kintor Pharmaceutical Limited (KNTPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kintor Pharmaceutical Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kintor Pharmaceutical Limited (KNTPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kintor Pharmaceutical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Kintor Pharmaceutical Limited's Current Ratio?

How is the Current Ratio calculated for Kintor Pharmaceutical Limited (KNTPF)?

What is the highest Current Ratio for Kintor Pharmaceutical Limited (KNTPF)?

What is the 3-year average Current Ratio for Kintor Pharmaceutical Limited (KNTPF)?

What is the 5-year average Current Ratio for Kintor Pharmaceutical Limited (KNTPF)?

How does the current Current Ratio for Kintor Pharmaceutical Limited (KNTPF) compare to its historical average?